TAVR specialists come together to explore new data, patient selection and much more

Michael Walter | June 05, 2025 | Cardiovascular Business | TAVR

A majority of medical devices involved in Class I recalls were never required by the U.S. Food and Drug Administration (FDA) to undergo premarket or postmarket clinical testing, according to new research published in Annals of Internal Medicine.[1]

Care teams have a lot to consider when choosing between transcatheter aortic valve replacement (TAVR) and surgical aortic valve replacement (SAVR) for patients with severe aortic stenosis. How old is the patient? Are they experiencing any other significant health issues?

These are just some of the questions that will be discussed during an upcoming webinar hosted by Cardiovascular Business and Medtronic. The webinar, “TAVR for Today’s Patient: Updates on Data, Risk, Anatomy and Access,” will include an in-depth discussion with three experienced heart specialists. A live Q&A session will follow.

Webinar participants include:

Kathryn Berlacher, MD, general cardiologist and medical director of the UPMC Magee Women's Heart Program
Michael Reardon, MD, cardiothoracic surgeon and chair of cardiovascular research at Houston Methodist Hospital
Angela Lowenstern, MD, interventional cardiologist and assistant professor of medicine at Vanderbilt University Medical Center

The panelists will touch on a variety of topics, including recent advances in TAVR technology, what the latest research tells us about the benefits of transcatheter treatments and the importance of engaging patients in shared decision-making.

This webinar was developed with a variety of attendees in mind, including general cardiologists, interventional cardiologists, structural heart specialists, cardiovascular service line directors, advanced practice providers and healthcare executives.

The webinar is scheduled for Tuesday, June 10, at 12:30 p.m. ET. Click here for to register for free or read over additional details.

Heart patients benefit when cardiologists follow a standardized TAVR protocol

Medtronic gains a key approval for Evolut TAVR valves

Physicians are leaning into supra-annular, self-expanding TAVR valves for women and small-annulus patients

Women with severe aortic stenosis remain underdiagnosed, undertreated—here’s how cardiologists can make a difference

Get SMART: Cardiologist says new TAVR data changed his perspective on treating women with symptomatic severe AS

Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Around the web

Health Exec

Major association of physicians presents itself as a go-to alternative vs. the government on vaccine expertise

One of the most formidable societies of medical professionals in the U.S. is going toe-to-toe with Robert F. Kennedy’s HHS over changing vaccination recommendations.

Health Exec

Tom Price: Medical residency slots need to expand to combat physician shortages

Tom Price, MD, former secretary of Health and Human Services (HHS), said one way to address the growing shortage of physicians is to expand medical resident positions, but these are tied to Medicare spending so alternative means may be needed.

Health Imaging

Tariffs will have a significant impact on the nuclear imaging supply chain in the US

"Domestic radiopharmaceutical suppliers, who receive isotopes from abroad, would be impacted by price changes and uncertainty caused by additional tariffs,” SNMMI President Cathy Cutler, PhD, wrote in a letter to the U.S. Department of Commerce this week.